United States Hereditary Genetic Testing Market By Technique (PCR, DNA Sequencing, Microarrays, Others), By Application (Cardiology, Oncology, Pharmacogenomics, Cognitive Dysfunction, Pathogenomics, Others), By Payer (Public Health Insurance, Private Health Insurance, Out of Pocket), By End User (Hospitals, Independent Laboratories), By Region, Competition Forecast & Opportunities, 2018-2028F
Published Date: November - 2024 | Publisher: MIR | No of Pages: 320 | Industry: Healthcare | Format: Report available in PDF / Excel Format
View Details Buy Now 2890 Download Sample Ask for Discount Request CustomizationUnited States Hereditary Genetic Testing Market By Technique (PCR, DNA Sequencing, Microarrays, Others), By Application (Cardiology, Oncology, Pharmacogenomics, Cognitive Dysfunction, Pathogenomics, Others), By Payer (Public Health Insurance, Private Health Insurance, Out of Pocket), By End User (Hospitals, Independent Laboratories), By Region, Competition Forecast & Opportunities, 2018-2028F
United States Hereditary Genetic Testing
According to the American Cancer Society, almost 1.8 million new patients with cancer were diagnosed in 2020. Around 606,520 cancer deaths were reported in the United States in 2020, making cancer the second-highest death-causing disease worldwide.
Growing Demand for Personalized Medicine
In addition, consumer awareness of personalized medicines increased to 33% in 2019 from 29% in 2018.
Download Free Sample ReportGrowing Advancement in Genetic Testing
Market Segmentation
United States Hereditary Genetic Testing
Recent Development
- For instance, in July 2020, MyriadGenetics, Inc. launched proprietary AMPLIFY technology, which increasesperformance of its Prequel noninvasive prenatal screening (NIPS) test.
- In addition, Myriad also launched NewGeneSight psychotropic patient collection kit in June 2020. This kit allows DNAsample collection, typically administered in a clinician’s office, to becompleted at home.
Market Players
Invitae Corporation, Ambry Genetics, BioReference Laboratories Inc, Progenity Inc., Pathema Gx Lab, LLC., Quest Diagnostics Incorporated, Myriad Genetics Inc., Fulgent Genetics, Inc., Burning Rock Biotech Limited
| Attribute | Details |
| Base Year | 2022 |
| Historic Data | 2018 – 2021 |
| Estimated Year | 2023 |
| Forecast Period | 2024 – 2028 |
| Quantitative Units | Revenue in USD Million, Volume in Units, and CAGR for 2018-2022 and 2023-2028 |
| Report Coverage | Revenue forecast, volume forecast, company share, competitive landscape, growth factors, and trends |
| Segments Covered | By Technique By Application By Payer By End User By Region |
| Regional scope | Northeast; Mid-West; West; South |
| Key companies profiled | Invitae Corporation, Ambry Genetics, BioReference Laboratories Inc.Progenity Inc., Pathema Gx Lab, LLC., Quest Diagnostics Incorporated, Myriad Genetics Inc., Fulgent Genetics,Inc., Burning Rock Biotech Limited. |
| Customization scope | 10% free report customization with purchase. Addition or alteration to country, regional & segment scope. |
| Pricing and purchase options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
| Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy